Clinical Trials · NCT07889648
A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Hoffmann-La Roche
- Enrollment
- 948
- Start date
- Dec 2026
- Locations
- See registry
- Primary endpoint
- Change From Baseline to Week 72 in Glycosylated Hemoglobin (HbA1c, %)